MedTrace Logo

Adherence and Quality of Life Across Three Different Intermittent Fasting Protocols in Obese Working Women

NCT07804329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-09-04

No results posted yet for this study

Summary

In these recent years, Intermittent Fasting (IF) has become popular among the public and health fraternities not only because it produced evidence-based results as an alternative dietary approach in weight loss strategy, but also putative for its practical implementation to link with daily routine. IF is defined as a range of dietary regimens involving fasting for an extended time period (16-48hrs) with little to no energy intake on fast day. However, there are many types of IF regiments with different methodological approaches, and results are inconsistent and debatable. Therefore, it has raised a question on which IF regimen design will possibly maximise the health benefit. Thus, the aim of this study is to identify IF regimens that are most feasible and acceptable to working women. The purpose of this study was to examine which type of IF regiment is more feasible for weight loss intervention programmes by prescribing three different types of IF to participants

Conditions

  • Obese Adults

Interventions

OTHER

Adherence to the IF Protocol

Adherence Percentage

OTHER

Quality of Life

Survey of PCS and MCS Score

Sponsors & Collaborators

  • Suriana Md Akir

    lead OTHER

Principal Investigators

  • Sareena Hanim Hamzah, Associate Proffesor · Faculty of Sports and Exercise Science

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-06-01
Completion
2023-06-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07804329 on ClinicalTrials.gov